Articles On Telix Pharmaceuticals (ASX:TLX)

The S&P/ASX 200 Index (ASX: XJO) had a wild start to this week's trading but overcame plenty of pessimism throughout the trading day to finish up in...

It's been a horror end to the trading week for the S&P/ASX 200 Index (ASX: XJO) this Friday. The ASX 200 fell sharply at market open, dropping as muc...

With the S&P/ASX 200 Index (ASX: XJO) rocketing more than 14% since the start of November, stock selection has now become critical. After all, you don't want to be buying an ASX stock after it has already become expensive. Every cent y...

ASX growth shares that are soaring rapidly are obviously exciting and rewarding to own. But, of course, one must always remember with reward comes risk. Not every hyper-growth stock you buy will end up a 10-bagger. Probably not even the ma...

MELBOURNE, Australia, March 12, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce the appointment of Dr. Darren Patti as Group Chief Operating Officer (COO), effective 11 March 2024....

Telix Pharmaceuticals Ltd (ASX: TLX) shares are up approximately 75% over the last 12 months. Investors have been buying the ASX 200 biotech stock after it reported explosive growth in FY 2023 last month. The company delivered a 214% incr...

On Friday, the S&P/ASX 200 Index (ASX: XJO) ended the week at a record high close. The benchmark index rose 1.1% to 7,847 points. Will the market be able to build on this on Monday? Here are five things to watch: ASX 200 expected to...

The S&P/ASX 200 Index (ASX: XJO) has concluded the week's trading on a decidedly high note. Literally. For today, the ASX 200 minted a fresh new all-time h...

Just $9,000 could start your journey into the delicious world of passive income. In fact, I reckon you're in with a shot of generating a perpetual monthly payment of $500 if you play your cards right. Don't believe me? Check out this hypot...

The ASX 200 traded sideways on Tuesday, closing the day flattish as gains in healthcare stocks were offset by losses in other sectors. Source: Market Index  Healthcare gained after the Albanese government approved an increase in private hea...

Australian biopharmaceutical company Telix Pharmaceuticals (ASX: TLX) is set to acquire Canadian radioisotope technology firm ARTMS Inc in a $125.9 million deal designed to boost its supply chain and production capacity. The deal will inclu...

Telix (ASX:TLX) will acquire radioisotope production technology firm ARTMS, its advanced cyclotron-based isotope production platform, manufacturing plant and a stockpile of ultra-pure rare metals required for consumable target produ...

MELBOURNE, Australia, March 5, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire radioisotope production technology firm ARTMS Inc. (ARTMS), its a...

The S&P/ASX 200 Index (ASX: XJO) snatched victory from the jaws of defeat today, recording a mild rise. After spending the whole day in red territory, the ASX 200...

Telix Pharmaceuticals strengthens its global presence by acquiring Texas-based IsoTherapeutics IsoTherapeutics, established in 2005, specialises in radiochemistry Telix’s strategic move aims to enhance in-house drug development, redu...

Telix (ASX:TLX) has announced total group revenue of $502.5 million for the 12 months to the end of December, up 214 per cent on the previous year.

MELBOURNE, Australia, Feb. 27, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire IsoTherapeutics Group, LLC (IsoTherapeutics), a specialty radioph...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((29M)) - 29Metals ((AX1)) - Accent Group ((AMA)) - AMA Group ((APA)) - APA Group ((LTM)) - Arcadium Lithium ((A1N)) - ARN Media ((ABB)) - Aussie Broadband ((ASB)) - Austa...

ASX gains on Nvidia-fuelled rally AI adjacent stocks, such as data centre companies, also surge Afterpay parent Block Inc surges 17pc, Newmont crashes 7pc   The ASX 200 gained around 0.4% as the AI craze swept through global stock markets...

Melbourne-based radiation oncology business Telix Pharmaceuticals has made its first-ever profit after strong sales for its prostate cancer imaging agent.

MELBOURNE, Australia, Feb. 22, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its results for the financial year ended 31 December 2023. All figures are in AUD$ unless otherwise stated.[1...

Of course, here at The Motley Fool we always recommend investors practise proper diversification to manage investment risk. But there's nothing wrong with fantasising about wild riches from a single ASX stock. It's just good, clean fun. Be...

It turned out to be a shaky, but still positive, start to the trading week for the S&P/ASX 200 Index (ASX: XJO) and most shares this Monday. By the close of trading tod...

When you're running your slide rule over S&P/ASX 200 Index (ASX: XJO) stocks to add to your portfolio, one metric to watch closely is the works it has in its pipeline. A strong pool of promising projects or products on the horizon shou...

If you're willing to put up with a little bit more risk than the average, there are some ASX stocks out there with the capability to rocket in a short amount of time. They potentially have some catalysts coming that, if they occur, could p...

ASX gained ground as the S&P 500 reached record highs AI mania continues as Arm Ltd surges 20pc after hours AGL Energy jumps on huge H1, News Corp surprises   The ASX 200 gained +0.3% on Thursday, tracking its counterparts in New York...

The ASX200 is set to trade flattish today with a mixed night on Wall Street, itself currently absorbing myriad big-name financial earnings updates. ASX200 futures were up 0.04 per cent near 8:30 am AEDT. It’s that time of year where b...

It's been a kind end to the November trading month for ASX investors today, with the S&P/ASX 200 Index (ASX: XJO) shaking off some early jitters...

MELBOURNE, Australia, Nov. 30, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that the completed Phase II OPALESCENCE investigator-initiated trial (IIT) of its carbonic anhydrase IX (CAIX)-...

I discussed earlier this month how it took a while for Tesla Inc (NASDAQ: TSLA) to become a brand name synonymous with the entire electric vehicle industry. Those investors courageous enough to buy split-adjusted US$1.13 shares at the init...

Sure, a million bucks no longer gets you an average house in Sydney. But becoming a millionaire still has a ring to it, right? The fact is you can still do plenty with a cool mill in the bank — not least retire on a comfortable lifestyle....

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.13% to 7,049.40. A muted finish to the week with winners and losers split fairly evenly on the ASX200....

The S&P/ASX 200 Index (ASX: XJO) has given investors a bit of a lacklustre finish to the trading week this Friday, recording a slight loss as we head in...

The Australian stock market concluded the trading session on a positive note on Tuesday, propelled by a resurgence in commodity prices, with anticipation building around the forthcoming US inflation update. The ASX200 index surged by 0.8%,...

The ASX200 has added .83 per cent today… fuelled largely by the energy sector which rallied more than 2.5 per cent and materials, IT, real estate and industrials also added at least a per cent. Utilities fell the hardest today, giving up...

ASX lifted on the back of commodities rally overnight Most energy and mining stocks rose Telstra down after update, mining services stock ALQ was best performer   The ASX climbed +0.9% on Tuesday on the back of a rebound in commodity pric...

Telix Pharmaceuticals (ASX:TLX) is set to acquire a private US company QSAM Biosciences develops bone cancer treatments CycloSam, AKA Samarium-153-DOTMP, is QSAM’s lead asset A therapeutic radiopharmaceutical, the treatment is fa...

Telix Pharmaceuticals (ASX:TLX) has announced that the first patient has been dosed in its Phase 3 ProstACT GLOBAL study of its investigational prostate-specific membrane antigen targeting radio-antibody drug conjugate therapy, TLX5...

MELBOURNE, Australia, Nov. 14, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed a conditional Term Sheet to acquire QSAM Biosciences, Inc. (QSAM) and its lead asset, CycloSam®...

MELBOURNE, Australia and PARIS, Nov. 13, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and Paris-based Mauna Kea Technologies (Euronext Growth: ALMKT, Mauna Kea), today announce an expansion of the IRiS...

MELBOURNE, Australia, Nov. 13, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in the Company’s Phase III ProstACT GLOBAL study of its investigational...

MELBOURNE, Australia, Nov. 8, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed an exclusive agreement with Denmark-based WIIK Pharma ApS (Wiik Pharma) for the distribution of...

Shares higher after US Fed’s decision to keep rates steady Rates-sensitive stocks, like Tech and Real Estate, rallied Origin Energy slumped after AustralianSuper rejected consortium’s bid   The ASX rose by almost 1% on Thursday, driven by...

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now...

It was another negative day, if only just, for the S&P/ASX 200 Index (ASX: XJO) and ASX shares this Wednesday. After investors enjoyed a reprieve from the recent selli...

There's no need to wait for the Boxing Day sales to pick up some mega stocktake bargains. Plenty of quality ASX companies have already had their prices slashed over the past few months of share market volatility. But while everyone loves...

Telix Pharmaceuticals has seen a 25% drop in its share price in the past four days as the market turns on the ASX's second-largest biotechnology company. Let's explore why. The post TELIX’s [ASX:TLX] Gains in the Year Halved as Sell-Off Co...

The wall of worry continues to pressure the Australian share market with the escalating conflict sending both the S&P/ASX200 (INDEXASX: XJO) share price and All Ordinaries (INDEXASX: XAO) share price more than 1% on Thursday. Falling 1....

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.36% to 6981.60. Markets @ Midday: Listen here at lunchtime or find all Market Matters Podcasts on Spotif...

The ASX200 has fallen more than 1.3 per cent today to sit well below the 7000 point mark and all 11 sectors firmly in the red. In the green But let’s look at the high achievers first… Whitebark Energy (ASX:WBE) added 47 per cent of...